New Fund
San Francisco-based AN Venture Partners closed a $200M fund to back biotech and life sciences companies, with a strong focus on innovations originating in Japan and global startups leveraging Japanese technology.
Palo Alto-based Accel announced it raised $5B to back late-stage,...
Silicon Valley-based Sequoia Capital secured $7B to double down on...
Palo Alto, CA-based Eclipse closed $1.311B across two funds to back...
Austin, Texas-based Overmatch Ventures announced a $250m second fund to...
San Carlos, CA-based Sonder Capital closed its second fund to back...
Woodland Hills, CA-based Celiac Disease Foundation launched a $15M...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
